Journal article

The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy

Leigh Ellis, Michael Bots, Ralph K Lindemann, Jessica E Bolden, Andrea Newbold, Leonie A Cluse, Clare L Scott, Andreas Strasser, Peter Atadja, Scott W Lowe, Ricky W Johnstone

Blood | AMER SOC HEMATOLOGY | Published : 2009

Grants

Awarded by National Health and Medical Research Council of Australia


Awarded by Leukemia & Lymphoma Society


Awarded by National Health and Medical Research Council of Australia RDWright Biomedical


Funding Acknowledgements

R.W.J. is a Pfizer Australia Research Fellow and was supported by the National Health and Medical Research Council of Australia (program grant 251608), the Cancer Council Victoria, the Leukemia Foundation of Australia, and the Bennelong Foundation. L. E. was supported by a postgraduate scholarship from the Leukemia Foundation of Australia. M. B. was supported by a Rubicon research grant from Netherlands Organisation for Scientific Research. A. S. was supported by the National Health and Medical Research Council of Australia (program grant 257502; Australia Fellowship) and the Leukemia & Lymphoma Society (New York, NY; Specialized Center of Research grant 7015). C. L. S. was supported by National Health and Medical Research Council of Australia RDWright Biomedical (CDA 406675).